| Financial Year |
March 31 2023 |
| Monetary Funds |
612,864,219.32 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
100,000.00 |
| Accounts Receivable |
466,423,805.69 |
| Advances to Suppliers |
145,619,385.68 |
| Other Receivables |
161,089,645.08 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
170,905,843.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
74,377,602.38 |
| Total Current Assets |
1,631,380,501.21 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
738,006.74 |
| Fixed Assetes |
2,436,050,996.22 |
| Under-construction Projects |
45,655,126.71 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
115,636,797.79 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,481,909.38 |
| Deferred Income Tax Assets |
6,206,363.49 |
| Other Non-Current Assets |
101,489,880.66 |
| Sub-Total of Non-Current Assets |
3,397,418,137.03 |
| Total Assets |
5,028,798,638.24 |
| Short-Term Loans |
2,567,900,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,864,373,075.35 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
72,562,194.18 |
| Taxes Payable |
8,843,421.44 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,142,558,049.76 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
227,724,383.83 |
| Other Current Liabilities |
7,245.28 |
| Sub-Total of Current Liabilities |
5,922,383,056.78 |
| Long-term Loans |
228,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
426,458,925.19 |
| Special Payable |
-- |
| Estimatied Liabilities |
7,579,927.57 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,206,216,745.92 |
| Total Liabilities |
7,128,599,802.70 |
| Paid-In Capital(Or Share Stock) |
532,832,976.00 |
| Capital Surplus |
455,854,425.26 |
| Surplus Reserve |
125,783,859.68 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-3,276,981,836.90 |
| Minority Stockholder's Interest |
21,563,467.79 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-2,121,364,632.25 |
| Owner's Equity（Stockholder's Equity） |
-2,099,801,164.46 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,028,798,638.24 |
